STRS Ohio
COAG icon

STRS Ohio’s Hemab Therapeutics COAG Stock Holding History

STRS Ohio’s Portfolio COAG Stock Details COAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$167K Buy
+5,400
New +$237K ﹤0.01% 1715

Other funds holding COAG

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

STRS Ohio's COAG Position: Q3 2026 in Review

STRS Ohio opened a new position in Hemab Therapeutics (COAG) in Q3 2026: 5,400 shares worth $167K. The stake represents ﹤0.01% of the portfolio and ranks #1715 among its holdings.

12 funds tracked by Wall St. Rank hold COAG as of Q3 2026.

  • STRS Ohio held 5,400 shares of Hemab Therapeutics worth $167K as of Q3 2026.
  • Hemab Therapeutics was a new STRS Ohio position in Q3 2026.
  • Hemab Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1715 holding.
  • 12 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.